Macrogen, Inc. (KOSDAQ:038290)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,970
-320 (-2.60%)
Jun 30, 2026, 3:30 PM KST
Market Cap129.77B -24.1%
Revenue (ttm)199.60B +37.6%
Net Income3.81B
EPS351.20
Shares Out 10.84M
PE Ratio34.08
Forward PE9.02
Dividend300.00 (2.44%)
Ex-Dividend DateDec 29, 2025
Volume24,668
Open12,290
Previous Close12,290
Day's Range11,600 - 12,370
52-Week Range11,000 - 20,900
Beta0.53
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 475
Stock Exchange KOSDAQ
Ticker Symbol 038290
Full Company Profile

Financial Performance

Financial Statements